Cargando…
A novel factor V mutation causes a normal activated protein C ratio despite the presence of a heterozygous F5 R506Q (factor V Leiden) mutation
Autores principales: | Prüller, Florian, Raggam, Reinhard B, Mangge, Harald, Truschnig-Wilders, Martie, Matzhold, Eva-Maria, Weiss, Eva-Christine, Hasiba, Barbara, Summers, Kelli L, Renner, Wilfried, Siegert, Gabriele, Kostka, Heike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153880/ https://www.ncbi.nlm.nih.gov/pubmed/23957718 http://dx.doi.org/10.1111/bjh.12506 |
Ejemplares similares
-
The prevalence of Factor V Leiden (Arg506Gln) mutation in King Khalid University Hospital patients, 2017–2019
por: Al-Otaiby, Maram, et al.
Publicado: (2021) -
Anticoagulation Therapy in a Patient With Heterozygous Factor V Leiden and Coexisting Homozygous Prothrombin Gene Mutations
por: Costa, Ryder L, et al.
Publicado: (2020) -
Papillophlebitis Associated With Coexisting Heterozygous Mutations of Factor V Leiden and Methylenetetrahydrofolate Reductase Enzyme-(C677T)
por: Ntora, Efthalia, et al.
Publicado: (2021) -
Sclerosing Mesenteritis in a Patient Heterozygous for Factor V Leiden
por: Reddington, Hayley, et al.
Publicado: (2020) -
COVID-19 infection in a heterozygous R506Q factor V mutation carrier progressing to DIC
por: Hassan, FI Abu, et al.
Publicado: (2023)